CareFusion, a global medical technology company, and Natus Medical Inc, a provider of health care screening, diagnostic, and treatment products, have entered into an agreement to sell the CareFusion Nicolet business to Natus for a cash purchase price of approximately $58 million.
"The decision to divest the Nicolet business is in line with our strategy to simplify and focus our operations and prioritize our investments to profitably grow over the long term," said Kieran Gallahue, chairman and CEO of CareFusion. "We have a dedicated team in the Nicolet business that will have greater scale and access to broader market opportunities as part of Natus."
The Nicolet business develops clinically differentiated neurodiagnostic and monitoring products, including a portfolio of electroencephalography (EEG) and electromyography (EMG) systems and related accessories, as well as vascular and obstetric Doppler sensors and connectivity products.
"The Nicolet acquisition will strengthen our existing neurology portfolio and provide us with new product categories," said Jim Hawkins, CEO of Natus. "Combining our strong product portfolio and support expertise with that of CareFusion’s Nicolet business will allow us to bring additional value to our customers.”
The acquisition is expected to close in July 2012, subject to customary closing conditions. The cash purchase price is subject to working capital adjustments. Natus plans to finance the acquisition with existing cash and borrowings under its revolving credit facility.
